AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32324850 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard of care for testing and treatment at public health facilities along with government‐sponsored mass long‐lasting insecticidal net [LLIN] distributions).
Number of subjects: 0
Study 35015187 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecedent-based techniques
Number of subjects: 90
Study 35015187 — intervention group
Group type: EXPERIMENTAL
Intervention: Consequent-based techniques
Number of subjects: 90
Study 35015187 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 90
Study 33793580 — intervention group
Group type: EXPERIMENTAL
Intervention: Branded Marevan
Number of subjects: 100
Study 33793580 — intervention group
Group type: COMPARATOR
Intervention: União Química generic warfarin
Number of subjects: 100
Study 33793580 — intervention group
Group type: COMPARATOR
Intervention: Teuto generic warfarin
Number of subjects: 100
Study 33378569 — intervention group
Group type: EXPERIMENTAL
Intervention: ibrutinib (IB)
Number of subjects: 675
Study 33378569 — intervention group
Group type: COMPARATOR
Intervention: idelalisib-rituximab (IDELA-R)
Number of subjects: 675
Study 36057254 — intervention group
Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE), 8 weeks, twice a week
Number of subjects: 28
Study 36057254 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 33632284 — intervention group
Group type: EXPERIMENTAL
Intervention: uniportal video-assisted thoracic surgery (u-VATS)
Number of subjects: 120
Study 33632284 — intervention group
Group type: COMPARATOR
Intervention: three-port video-assisted thoracic surgery (t-VATS)
Number of subjects: 120
Study 32730183 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP-14
Number of subjects: 574
Study 32730183 — intervention group
Group type: EXPERIMENTAL
Intervention: RR-CHOP-14
Number of subjects: 574
Study 35974310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided alveolar recruitment manoeuvres (UD group)
Number of subjects: 0
Study 35974310 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained inflation alveolar recruitment manoeuvres (SI group)
Number of subjects: 0
Study 35974310 — intervention group
Group type: COMPARATOR
Intervention: No recruitment manoeuvres (C group)
Number of subjects: 0
Study 34698652 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered booster sessions (N=245)
Number of subjects: 739
Study 34698652 — intervention group
Group type: COMPARATOR
Intervention: Web-delivered booster sessions (N=246)
Number of subjects: 739
Study 34043475 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic-index (HGI) meal
Number of subjects: 18
Study 34043475 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic-index (LGI) meal
Number of subjects: 18
Study 33415872 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) applied at Zusanli (ST 36), Xuehai (SP 10), Sanyinjiao (SP 6) for 30 min each time, twice daily for 5 days.
Number of subjects: 120
Study 33415872 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing combined with early functional exercise (20 min each time, twice daily for 5 days).
Number of subjects: 120
Study 33415872 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation training (20 min each time, twice daily for 5 days).
Number of subjects: 120
Study 33538548 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic CBD exploration with cholecystectomy (group I)
Number of subjects: 77
Study 33538548 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST) followed by laparoscopic cholecystectomy (group II)
Number of subjects: 77
Study 32556595 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride (KCl) supplementation
Number of subjects: 26
Study 32556595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 32975171 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder and scapula muscle training plus conventional physiotherapy
Number of subjects: 48
Study 32975171 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 48
Study 33098678 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose radiation (HDR, 45 + 18 Gy)
Number of subjects: 207
Study 33098678 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiochemotherapy (RCT, 45 Gy + 5FU infusion)
Number of subjects: 207
Study 33098678 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphincter-saving surgery (SSR)
Number of subjects: 207
Study 33098678 — intervention group
Group type: COMPARATOR
Intervention: Abdominoperineal resection (APR)
Number of subjects: 207
Study 32615237 — intervention group
Group type: EXPERIMENTAL
Intervention: FDI criteria
Number of subjects: 160
Study 32615237 — intervention group
Group type: COMPARATOR
Intervention: CARS criteria
Number of subjects: 160
Study 34275868 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based distribution of HIV self-tests (HIVST) using OraQuick HIVST kits over 12 months.
Number of subjects: 148541
Study 34275868 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 148541
Study 34275868 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based distribution of HIV self-tests (HIVST)
Number of subjects: 148541
Study 34024247 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.7 kg MB
Number of subjects: 31
Study 34024247 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6 kg MB
Number of subjects: 31
Study 34024247 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 kg MB
Number of subjects: 31
Study 34024247 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5 kg MB
Number of subjects: 31
Study 35745183 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive mobile nutritional education for a year
Number of subjects: 203
Study 35745183 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 203
Study 34321204 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (genetic variants associated with testosterone levels)
Number of subjects: 306248
Study 32057976 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC-guided laser lithotripsy (SOC-LL)
Number of subjects: 66
Study 32057976 — intervention group
Group type: COMPARATOR
Intervention: Large balloon sphincteroplasty (LBS)
Number of subjects: 66
Study 35441943 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-orifice epidural catheter (group E)
Number of subjects: 100
Study 35441943 — intervention group
Group type: COMPARATOR
Intervention: Conventional application (group C)
Number of subjects: 100
Study 32761047 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-bone-borne (TBB) rapid maxillary expansion
Number of subjects: 52
Study 32761047 — intervention group
Group type: COMPARATOR
Intervention: Tooth-borne (TB) rapid maxillary expansion
Number of subjects: 52
Study 33872957 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 78
Study 33872957 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 78
Study 35571974 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT), provided monthly for up to six months
Number of subjects: 9
Study 35571974 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 9
Study 35201924 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology (30 minutes twice per week for 6 weeks)
Number of subjects: 100
Study 35201924 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm foot-bath (1 hour before bedtime every evening for 6 weeks)
Number of subjects: 100
Study 35201924 — intervention group
Group type: COMPARATOR
Intervention: Foot reflexology
Number of subjects: 100
Study 35201924 — intervention group
Group type: COMPARATOR
Intervention: Warm foot-bath
Number of subjects: 100
Study 32212932 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert recommendations (attainable)
Number of subjects: 345
Study 32212932 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer information (less attainable)
Number of subjects: 345
Study 32212932 — intervention group
Group type: COMPARATOR
Intervention: No-feedback control
Number of subjects: 345
Study 35349976 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose minocycline (10 mg/kg)
Number of subjects: 11
Study 35349976 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 11
Study 33453782 — intervention group
Group type: EXPERIMENTAL
Intervention: PRAISE score (machine learning-based risk stratification model)
Number of subjects: 19826
Study 35349953 — intervention group
Group type: EXPERIMENTAL
Intervention: PIO-5 (5 mg PIO/bird/day)
Number of subjects: 24
Study 35349953 — intervention group
Group type: EXPERIMENTAL
Intervention: PIO-10 (10 mg PIO/bird/day)
Number of subjects: 24
Study 35349953 — intervention group
Group type: COMPARATOR
Intervention: Control (basal diet)
Number of subjects: 24
Study 36415112 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine triple therapy (berberine, amoxicillin, rabeprazole)
Number of subjects: 524
Study 36415112 — intervention group
Group type: COMPARATOR
Intervention: Standard bismuth quadruple therapy (amoxicillin, rabeprazole, clarithromycin, bismuth tartrate)
Number of subjects: 524
Study 32654080 — intervention group
Group type: EXPERIMENTAL
Intervention: All urate-lowering therapies (ULTs)
Number of subjects: 7968
Study 32654080 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat 80/120/240 mg/day
Number of subjects: 7968
Study 32654080 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesinurad in combination with febuxostat or allopurinol
Number of subjects: 7968
Study 32654080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7968
Study 33478875 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-slider method (WSM)
Number of subjects: 0
Study 33478875 — intervention group
Group type: COMPARATOR
Intervention: Conventional suction retrieval (non-WSM)
Number of subjects: 0
Study 35325258 — intervention group
Group type: EXPERIMENTAL
Intervention: HARPdoc cohort
Number of subjects: 99
Study 35325258 — intervention group
Group type: COMPARATOR
Intervention: Comparator group (n=81)
Number of subjects: 99
Study 34636463 — intervention group
Group type: EXPERIMENTAL
Intervention: Djulis functional drinks (50 ml daily for 8 weeks)
Number of subjects: 30
Study 34636463 — intervention group
Group type: COMPARATOR
Intervention: Placebo drinks (50 ml daily for 8 weeks)
Number of subjects: 30
Study 34103473 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose hUC-MSC (1.5 × 10^6/kg body weight)
Number of subjects: 72
Study 34103473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hUC-MSC (0.5 × 10^6/kg body weight)
Number of subjects: 72
Study 34103473 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 72
Study 34103473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hUC-MSC
Number of subjects: 72
Study 32333337 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBM) - 24 sessions, 810 nm, 5 diodes × 200 mW, 30 J/application site
Number of subjects: 28
Study 32333337 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no physical therapy intervention, only underwent hemodialysis (HD) sessions
Number of subjects: 28
Study 32700100 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic anti-reflux surgery (LARS)
Number of subjects: 25
Study 35391541 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + GCSF at 10 ug/kg in 3 daily doses within 4 days of Kasai
Number of subjects: 218
Study 35391541 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + GCSF
Number of subjects: 218
Study 35391541 — intervention group
Group type: COMPARATOR
Intervention: SOC + NO-GCSF
Number of subjects: 218
Study 34797293 — intervention group
Group type: EXPERIMENTAL
Intervention: Danhong injection
Number of subjects: 0
Study 34797293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32608055 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessments (including BMI, pain duration, repeated single step-ups to pain onset)
Number of subjects: 179
Study 32608055 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression analysis
Number of subjects: 179
Study 32134290 — intervention group
Group type: EXPERIMENTAL
Intervention: OurRelationship program
Number of subjects: 742
Study 32134290 — intervention group
Group type: EXPERIMENTAL
Intervention: ePREP program
Number of subjects: 742
Study 32134290 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 742
Study 32109883 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dribble (RD)
Number of subjects: 10
Study 32109883 — intervention group
Group type: COMPARATOR
Intervention: No dribble (ND)
Number of subjects: 10
Study 32109883 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 vs 3 format
Number of subjects: 10
Study 32109883 — intervention group
Group type: COMPARATOR
Intervention: 5 vs 5 format
Number of subjects: 10
Study 32109883 — intervention group
Group type: COMPARATOR
Intervention: 4 vs 4 format
Number of subjects: 10
Study 35030634 — intervention group
Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel (JULIET study)
Number of subjects: 0
Study 35030634 — intervention group
Group type: COMPARATOR
Intervention: Historical treatments (CORAL study)
Number of subjects: 0
Study 32036482 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Hilyses supplementation
Number of subjects: 270
Study 32036482 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% Hilyses supplementation
Number of subjects: 270
Study 32036482 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 270
Study 35502773 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 33368290 — intervention group
Group type: EXPERIMENTAL
Intervention: Cr-yeast
Number of subjects: 540
Study 33368290 — intervention group
Group type: EXPERIMENTAL
Intervention: CrMet
Number of subjects: 540
Study 33368290 — intervention group
Group type: EXPERIMENTAL
Intervention: CrNic
Number of subjects: 540
Study 36480560 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg/day) for 6 months
Number of subjects: 84
Study 36480560 — intervention group
Group type: COMPARATOR
Intervention: Control (statin non‐users)
Number of subjects: 84
Study 34003226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate
Number of subjects: 2374
Study 34003226 — intervention group
Group type: COMPARATOR
Intervention: Calcium Carbonate
Number of subjects: 2374
Study 32901778 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telemonitoring system (IN group)
Number of subjects: 154
Study 32901778 — intervention group
Group type: COMPARATOR
Intervention: Standard care (OUT group)
Number of subjects: 154
Study 35610318 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion with loading dose group (GpIII)
Number of subjects: 48
Study 35610318 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion without loading dose group (GpII)
Number of subjects: 48
Study 35610318 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent group (GpI)
Number of subjects: 48
Study 34243738 — intervention group
Group type: EXPERIMENTAL
Intervention: PathMate2 group (PM) - daily conversational agent counselling via mobile app, combined with standardized counselling (4 on-site visits) for 5.5 months.
Number of subjects: 41
Study 34243738 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) - multi-component behaviour changing intervention (BCI) with 7 on-site visits for 5.5 months.
Number of subjects: 41
Study 34243738 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback relaxation exercises (part of the intervention for both groups).
Number of subjects: 41
Study 33278291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 4 mg dexamethasone
Number of subjects: 75
Study 33278291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 75
Study 33278291 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 75
Study 32267989 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) trial duration >10 days
Number of subjects: 174
Study 32267989 — intervention group
Group type: COMPARATOR
Intervention: Spinal cord stimulation (SCS) trial duration ≤10 days
Number of subjects: 174
Study 32267989 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial duration median 21 days for those with infection
Number of subjects: 174
Study 32267989 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial duration median 21.5 days in Belgium
Number of subjects: 174
Study 32267989 — intervention group
Group type: COMPARATOR
Intervention: Trial duration median 5.8 days in other countries
Number of subjects: 174
Study 36414947 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (1000 mg natural fish oil soft-gels daily for 3 months)
Number of subjects: 30
Study 36414947 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil soft-gels (control group)
Number of subjects: 30
Study 32072879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-referencing messages in a narrative
Number of subjects: 146
Study 32072879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-referencing messages highlighting health risks of obesity
Number of subjects: 146
Study 34120898 — intervention group
Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 2198
Study 32114875 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal axillary vein approach
Number of subjects: 99
Study 32114875 — intervention group
Group type: COMPARATOR
Intervention: Distal axillary vein approach
Number of subjects: 99
Study 34406366 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral abrocitinib 200 mg
Number of subjects: 285
Study 34406366 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral abrocitinib 100 mg
Number of subjects: 285
Study 34406366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study 34406366 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 285
Study 33325757 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 90
Study 33325757 — intervention group
Group type: EXPERIMENTAL
Intervention: MenC-CRM
Number of subjects: 90
Study 34267582 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 Hz vibration
Number of subjects: 19
Study 34267582 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Hz vibration
Number of subjects: 19
Study 34267582 — intervention group
Group type: COMPARATOR
Intervention: 0 Hz vibration (control)
Number of subjects: 19
Study 34267582 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency lower-body vibration (LBV)
Number of subjects: 19
Study 32172686 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual coping through adherence measures (interview or daily phone diary)
Number of subjects: 25
Study 32172686 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual constructs
Number of subjects: 25
Study 32172686 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative analysis of spirituality's role
Number of subjects: 25
Study 35398306 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary implantation of an intraocular lens (IOL)
Number of subjects: 0
Study 35398306 — intervention group
Group type: COMPARATOR
Intervention: Contact lens correction after being left aphakic
Number of subjects: 0
Study 33452288 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 30
Study 33452288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 30
Study 33452288 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) tDCS
Number of subjects: 30
Study 33452288 — intervention group
Group type: COMPARATOR
Intervention: Comparison of tDCS groups vs. Sham
Number of subjects: 30
Study 35303094 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cathodal HD tDCS targeting left IFG
Number of subjects: 67
Study 35303094 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cathodal HD tDCS targeting left DLPFC
Number of subjects: 67
Study 32588238 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-duration DAPT (≥ 12 months)
Number of subjects: 5131
Study 32588238 — intervention group
Group type: COMPARATOR
Intervention: Short-duration DAPT (≤ 6 months)
Number of subjects: 5131
Study 32481332 — intervention group
Group type: EXPERIMENTAL
Intervention: Tong Jing Tiao Xing tuina (TJTX) once a day, Excising with scalp acupuncture (ESA) once a day, and oral Yinao fujian formula (YNFJ) twice a day for 5 sessions a week for 4 weeks.
Number of subjects: 316
Study 32481332 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT) for 5 sessions a week for 4 weeks.
Number of subjects: 316
Study 36196767 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonazoid-enhanced ultrasound (SZUS)
Number of subjects: 105
Study 36196767 — intervention group
Group type: COMPARATOR
Intervention: SonoVue-enhanced ultrasound (SVUS)
Number of subjects: 105
Study 36196767 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonazoid-enhanced ultrasound (SZUS) with 5-minutes washout criterion
Number of subjects: 105
Study 36196767 — intervention group
Group type: COMPARATOR
Intervention: SonoVue-enhanced ultrasound (SVUS) with 5-minutes washout criterion
Number of subjects: 105
Study 32354671 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotion of HPV vaccination
Number of subjects: 278
Study 32354671 — intervention group
Group type: COMPARATOR
Intervention: Promotion of healthy eating and appropriate nutrition label interpretation
Number of subjects: 278
Study 34590545 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem-based standing on foam with an externally focused dual-task (TBFE)
Number of subjects: 32
Study 34590545 — intervention group
Group type: COMPARATOR
Intervention: Baseline single task (TBF)
Number of subjects: 32
Study 33040491 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 53
Study 33922576 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose strawberry powder (32 g/day)
Number of subjects: 33
Study 33922576 — intervention group
Group type: COMPARATOR
Intervention: Low dose strawberry powder (13 g/day)
Number of subjects: 33
Study 33922576 — intervention group
Group type: COMPARATOR
Intervention: Control powder
Number of subjects: 33
Study 35399845 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam combined with warm acupuncture (JG)
Number of subjects: 81